analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik
IDH-AC-000-อส6302/30.00 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended 31 December 2019 To: President The Stock Exchange of Thailand Overview of the
Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.4/2020, held on August 14, 2020, has approved the financial statements of the
Management Discussion and Analysis for the year ended December 31, 2019 Attention The President The Stock Exchange of Thailand Attachment Report and financial statement for the year ended December 31, 2019
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
the face of these challenges, AIS’s execution focusing on profitable revenue brought in a core service revenue of Bt33,351mn, growing 2.3% YoY. This growth was driven by the continued expansion of fixed
economy demonstrated cautious growth driven by tourism-related sector expansion and subsided inflation, while facing political uncertainties and global economic risks. AIS core service revenue reported at
healthy growth from quality acquisition. Fixed broadband revenue recorded at Bt3,021mn, a strong growth of 19% YoY and 5.8% QoQ resulted from a continuous expansion into upcountry areas to capture new
หน้า 1 ของ 3 (Translation) No. ACC6702/001 February 28, 2024 Subject: Clarification of operating results for the Annual Year 2023 (Revised) To: The President, The Stock Exchange of Thailand Advanced
investors, which can lead to business expansion, employment, and more competitive edge of local businesses. This translates into the overall economic benefits of the country at large thanks to a close